Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01373840 · ClinicalTrials.gov registry record
Role of Dopamine Receptors in Primary Focal Dystonias
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 40
- Enrollment target
NCT01373840 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 40 participants.
The verdict
NCT01373840 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Dystonia is a disabling movement disorder characterized by repetitive patterned or sustained muscle contractions causing twisting or abnormal postures that may afflict 250,000 people in the U.S. While the pathophysiology of dystonia remains uncertain the treatment is rather rudimentary. A better understanding of neural mechanisms of dystonias is not only an invaluable prerequisite for developing better treatment options but also a step toward better understanding of the complex network of basal ganglia. In this study I will investigate if there is any difference between the dopamine receptors and dopamine in people with dystonia and healthy subjects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-09 |
| Est. Completion | 2016-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01373840
The ClinicalTrials.gov registry entry for NCT01373840 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01373840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01373840 about?
NCT01373840 is a clinical study titled "Role of Dopamine Receptors in Primary Focal Dystonias". Dystonia is a disabling movement disorder characterized by repetitive patterned or sustained muscle contractions causing twisting or abnormal postures that may afflict 250,000 people in the U.S. While the pathophysiology of dystonia remains uncertain the treatment is rather rudimentary. A better und...
What is the current status of trial NCT01373840?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2011-09. Estimated completion is 2016-04.
Who is sponsoring clinical trial NCT01373840?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.